IMMUNOCORE HLDGS ADS/1 Defensive Interval Ratio
IMMUNOCORE HLDGS ADS/1 defensive interval ratio. IMMUNOCORE HLDGS ADS/1 (6YG) has a Defensive Interval Ratio of 761 days as of June 2026. Defensive assets of €490.64 Million (cash €-, short-term investments €395.29 Million, receivables €95.35 Million) cover 761 days of daily cash needs of €644.38K/day. See IMMUNOCORE HLDGS ADS/1 (6YG) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Defensive Interval Ratio of IMMUNOCORE HLDGS ADS/1 (2022–2025)
Defensive interval ratio of IMMUNOCORE HLDGS ADS/1 from 2022 to 2025. This chart shows how IMMUNOCORE HLDGS ADS/1's Defensive Interval Ratio has evolved across 4 annual periods from 2022 to 2025. As of June 2026, the ratio stands at 761 days, meaning defensive assets of €490.64 Million can fund 761 days of operations without new revenue. Check 6YG financial resilience to evaluate the company's liquid asset resilience ratio.
IMMUNOCORE HLDGS ADS/1 Defensive Interval Ratio by Year (2022–2025)
IMMUNOCORE HLDGS ADS/1 defensive interval ratio by year from 2022 to 2025. The table below presents the year-by-year Defensive Interval Ratio for IMMUNOCORE HLDGS ADS/1 from 2022 to 2025, covering 4 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see IMMUNOCORE HLDGS ADS/1 assets under control.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 696 days | €470.42 Million | €675.88K/day | €- | €396.44 Million | ▼ -40 days |
| 2024 | 736 days | €427.65 Million | €581.32K/day | €- | €364.64 Million | ▲ +599 days |
| 2023 | 137 days | €52.09 Million | €380.88K/day | €- | €0.00 | ▲ +15 days |
| 2022 | 122 days | €33.58 Million | €276.26K/day | €- | €- | — |